unknown
Stage
1
Investors
About
Ascidian Therapeutics is a biotechnology company developing RNA therapeutics that edit and replace mutated human exons to restore normal protein production for genetically defined diseases.
Explore Ascidian Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.